Stock gains in 2025 are driven by tech innovation, boosting smaller companies like Blueprint Medical (BPMC). BPMC, a biopharma company, surged due to strong revenue outlook, new data, and positive results for its products targeting allergies, inflammation, and cancers.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing